AIM Rega marang bathi mangsa ngarep AIM ImmunoTech
AIM ImmunoTech focuses on developing Ampligen-based immunomodulators to combat viruses and oncology. The issuer's forward P/E visualizes the market value of the expected profit share, while 0.00 shows the current value of this metric. Robotic screening systems ensure development efficiency, and business growth relies on research alliances with medical consortia without the acquisition of startups.
aimimmuno.com (AIM) - rincian metrik lan laporan keuangan
- kuotasi lan prakiraan analis:
- data kapitalisasi pasar:
- data ekuitas miturut neraca:
- indikator beban kredit lan likuiditas emiten:
Utang marang Ekuitas AIM ImmunoTech|AIM - Rasio utang jangka dawa marang modal|Utang jangka cendhak marang modal AIM ImmunoTech Inc.|AIM - Utang kumulatif perusahaan|Utang-utang marang kapitalisasi buku AIM ImmunoTech, Inc.|AIM - Utang jangka dawa perusahaan|Utang jangka cendhak perusahaan AIM ImmunoTech|Likuiditas cepet aimimmuno.com
- indikator profitabilitas perusahaan lan kelipatan valuasi:
AIM - Penghasilan resik|Bathi mangsa ngarep AIM ImmunoTech|AIM - Nilai perusahaan marang bathi resik|Pangali Forward P/E AIM ImmunoTech|AIM - Kapitalisasi marang bathi resik kanthi nimbang wutah|Nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan AIM ImmunoTech, Inc.|AIM - Bathi operasional sadurunge ngurangi amortisasi|Bathi saben saham sajrone rolas wulan pungkasan AIM ImmunoTech|AIM - Bathi resik saben saham sajrone 12 wulan pungkasan|Wutah bathi resik saben saham taun-ka-taun sajrone 12 wulan pungkasan aimimmuno.com|AIM - Wutah bathi ing taun lumaku|Prakiraan wutah bathi resik saben saham kanggo taun ngarep AIM ImmunoTech
Analisis kabeh metrik perusahaan:AIM ImmunoTech
The market assesses the potential of AIM ImmunoTech through the lens of expected earnings, where the company's forward P/E compares the current quote with yield forecasts to identify value inflection points. Analyzing the forward P/E of AIM ImmunoTech allows for an evaluation of intellectual property protection efficiency and cost transparency, determining whether a low multiple represents a defensive asset or a signal of stagnation within the biopharmaceutical business.
Analisis perusahaan pesaing
Pangali Forward P/E ARGX|Kapitalisasi marang proyeksi bathi BioNTech Inc.|Rega marang bathi mangsa ngarep abivax.com ABVX|ADMA - Prakiraan rega marang bathi|PTGX - Rega marang bathi mangsa ngarep|immunovant.com (IMVT) - Prakiraan rega marang bathi|KNSA (Kiniksa) - Prakiraan rega marang bathi|Grifols SA (GRFS) - Pangali Forward P/E|Rega marang bathi mangsa ngarep Adaptive Biotechnologies Corp|Rasio rega marang bathi mangsa ngarep CLDX (Celldex Corp)|Pangali Forward P/E AUPH|BCRX - Rasio prakiraan rega marang bathi|Pangali Forward P/E VERA (Vera Therapeutics)|Pangali Forward P/E Dianthus Therapeutics Inc DNTH|Pharvaris Corp - Pangali Forward P/E|Kapitalisasi marang proyeksi bathi AbCellera Biologics ABCL|Tourmaline Bio, Inc. (TRML) - Rega marang bathi mangsa ngarep|Prakiraan rega marang bathi precigen.com|Prakiraan rega marang bathi PHAR|NKTR: Pangali mangsa ngarep rega marang bathi|Pangali Forward P/E UPB|Kapitalisasi marang proyeksi bathi Zenas Corp|Rega marang bathi mangsa ngarep Immunome, Inc. IMNM|GOSS - Prakiraan rega marang bathi|KALV - Rega marang bathi mangsa ngarep|Septerna, Inc. (SEPN) - Prakiraan rega marang bathi|PVLA (Pieris Pharmaceuticals Inc) - Prakiraan rega marang bathi|Savara Pharma (SVRA) - Pangali Forward P/E|Rega marang bathi mangsa ngarep Rigel Pharmaceuticals|Rasio rega marang bathi mangsa ngarep ANAB (anaptysbio.com)|Rega marang bathi mangsa ngarep Astria Therapeutics, Inc. (ATXS)|ENGN - Rasio prakiraan rega marang bathi|RAPT Therapeutics, Inc. - Prakiraan rega marang bathi|Rasio kapitalisasi marang bathi mangsa ngarep JBIO (Aerovate Therapeutics, Inc.)|Aclaris Therapeutics - Pangali Forward P/E|Rasio prakiraan rega marang bathi kyvernatx.com|TLSA: Pangali Forward P/E|Prakiraan rega marang bathi Cabaletta Bio Inc.|VTYX (Ventyx Bio) - Pangali Forward P/E|THTX: Pangali mangsa ngarep rega marang bathi|Pangali Forward P/E AVTX|Pangali Forward P/E eledon.com (ELDN)|Pangali Forward P/E AGEN (Agenus Inc.)|Kapitalisasi marang proyeksi bathi Climb Bio Inc. (CLYM)|ZURA - Rega marang bathi mangsa ngarep|aTyr Pharmaceuticals (ATYR) - Prakiraan rega marang bathi|adagene.com (ADAG) - Rega marang bathi mangsa ngarep|Rasio rega marang bathi sing dikarepake IMA (Ikena Oncology)|STTK (Shattuck Labs Inc) - Pangali Forward P/E|EQ: Pangali mangsa ngarep rega marang bathi|Pangali Forward P/E CNTB|Pangali Forward P/E immunic-therapeutics.com (IMUX)|Rega marang bathi mangsa ngarep Atara Bio ATRA|Pangali mangsa ngarep rega marang bathi IFRX|XFOR - Rega marang bathi mangsa ngarep|Adicet Bio (ACET) - Prakiraan rega marang bathi|CELU: Pangali Forward P/E|INmune Bio Corporation (INMB) - Pangali Forward P/E|Prakiraan rega marang bathi BRNS|KZR: Pangali mangsa ngarep rega marang bathi|Pangali Forward P/E SABS|Kapitalisasi marang proyeksi bathi Akari Therapeutics PLC|Rega marang bathi mangsa ngarep Enlivex Therapeutics Ltd. ENLV|QTTB - Prakiraan rega marang bathi|GOVX - Rega marang bathi mangsa ngarep|edesabiotech.com (EDSA) - Prakiraan rega marang bathi|IBIO (iBio) - Prakiraan rega marang bathi|Carisma Therapeutics Inc. (CARM) - Pangali Forward P/E|Rega marang bathi mangsa ngarep XTL Biopharmaceuticals, Ltd.|Rasio rega marang bathi mangsa ngarep BOLT (Bolt Bio)|Pangali Forward P/E HCWB|APVO - Rasio prakiraan rega marang bathi|Pangali Forward P/E ADTX (Aditxt, Inc.)|Pangali Forward P/E GRI Bio Inc GRI|XORTX - Pangali Forward P/E|Kapitalisasi marang proyeksi bathi Vyome Therapeutics HIND|Revelation Biosciences (REVB) - Rega marang bathi mangsa ngarep|Prakiraan rega marang bathi indaptusrx.com|Prakiraan rega marang bathi SCNI|CALI: Pangali mangsa ngarep rega marang bathi|Pangali Forward P/E AFMD|Kapitalisasi marang proyeksi bathi allakos.com|Rega marang bathi mangsa ngarep HOOKIPA Pharma HOOK|IGMS - Prakiraan rega marang bathi|ITOS - Rega marang bathi mangsa ngarep|Ocean Biomedical Inc (OCEA) - Prakiraan rega marang bathi|TCBP (TC BioPharm (Holdings) PLC) - Prakiraan rega marang bathi|Third Harmonic Bio Inc (THRD) - Pangali Forward P/E
